Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension

Table 2

The prediction of pre- and post-TAVR pulmonary hypertension.

Variables	Pre-TAVR PH			Post-TAVR PH
	OR	95% CI	value	OR	95% CI	value
BMI (kg/m^2)	0.747	0.585–0.952	0.018	0.892	0.771–1.032	0.124
HB (g/L)				0.993	0.968–1.018	0.582
PLR	0.988	0.976–1.000	0.045
NLR	1.266	1.047–1.530	0.015
RDW_SD	1.073	0.970–1.186	0.172	1.083	1.000–1.173	0.050
BNP (ng/L)	1.000	0.999–1.001	0.798
TG (mmol/l)	0.660	0.233–1.867	0.433
UA (mmol/L)	0.998	0.992–1.004	0.486	1.001	0.998–1.004	0.493
ALT	1.009	0.964–1.056	0.714
T-BIL	1.038	0.920–1.171	0.543
r-GT	1.031	1.008–1.053	0.007
RVD (mm)	1.142	0.749–1.742	0.537
LAVI (ml/m^2)	1.097	1.006–1.197	0.036	1.000	0.953–1.049	0.992
PAD (mm)	1.574	1.096–2.261	0.014	1.241	1.035–1.488	0.020
LVEF (%)	0.953	0.873–1.040	0.280
E/e′ ratio	1.083	0.971–1.208	0.154	1.050	0.978–1.127	0.175
Peak AV pressure (mmHg)	1.050	1.017–1.084	0.003

TAVR, transcatheter aortic valve replacement; PH, pulmonary hypertension; BMI, body mass index; HB, hemoglobin; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-lymphocyte-ratio; RDW_SD, the red cell distribution width_Standard Deviation; BNP, B-type natriuretic peptide; TG, triglyceride; UA, uric acid; ALT, alanine aminotransferase; T-BIL, serum total bilirubin; r-GT, r-glutamyltranspeptidase; RVD, right ventricular diastolic diameter; LAVI, left atrial volume index; PAD, pulmonary artery diameter; LVEF, left ventricular ejection fraction; E/e′, early diastolic transmitral flow velocity/lateral mitral annular myocardial velocity; AV, aortic valve. , vs. No PH. The bold values indicate statistical significances ().